These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25446950)

  • 1. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications.
    Rajasekaran A; Venkatasubramanian G; Berk M; Debnath M
    Neurosci Biobehav Rev; 2015 Jan; 48():10-21. PubMed ID: 25446950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.
    Venkatasubramanian G; Debnath M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():301-11. PubMed ID: 23587629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression.
    Anderson G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():5-19. PubMed ID: 22800757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in the major histocompatibility complex [MHC] gene family in schizophrenia: associations and functional implications.
    Debnath M; Cannon DM; Venkatasubramanian G
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():49-62. PubMed ID: 22813842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
    Clay HB; Sillivan S; Konradi C
    Int J Dev Neurosci; 2011 May; 29(3):311-24. PubMed ID: 20833242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways of mitochondrial dysfunctions: possible cause of cell death in anesthesia-induced developmental neurotoxicity.
    Li L; Yu Q; Liang W
    Brain Res Bull; 2015 Jan; 110():14-9. PubMed ID: 25451455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia.
    Altamura AC; Buoli M; Pozzoli S
    Psychiatry Clin Neurosci; 2014 Jan; 68(1):21-36. PubMed ID: 24102953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria, synaptic plasticity, and schizophrenia.
    Ben-Shachar D; Laifenfeld D
    Int Rev Neurobiol; 2004; 59():273-96. PubMed ID: 15006492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox dysregulation, neurodevelopment, and schizophrenia.
    Do KQ; Cabungcal JH; Frank A; Steullet P; Cuenod M
    Curr Opin Neurobiol; 2009 Apr; 19(2):220-30. PubMed ID: 19481443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries.
    Davis J; Moylan S; Harvey BH; Maes M; Berk M
    Aust N Z J Psychiatry; 2014 Jun; 48(6):512-29. PubMed ID: 24803587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular links between mitochondrial dysfunctions and schizophrenia.
    Park C; Park SK
    Mol Cells; 2012 Feb; 33(2):105-10. PubMed ID: 22358509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.
    Ben-Shachar D
    Schizophr Res; 2017 Sep; 187():3-10. PubMed ID: 27802911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria in health and disease: perspectives on a new mitochondrial biology.
    Duchen MR
    Mol Aspects Med; 2004 Aug; 25(4):365-451. PubMed ID: 15302203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment.
    Debnath M
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):610-9. PubMed ID: 26162591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria.
    James R; Adams RR; Christie S; Buchanan SR; Porteous DJ; Millar JK
    Mol Cell Neurosci; 2004 May; 26(1):112-22. PubMed ID: 15121183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine.
    Ben-Shachar D
    J Neurochem; 2002 Dec; 83(6):1241-51. PubMed ID: 12472879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging.
    Wang CH; Wu SB; Wu YT; Wei YH
    Exp Biol Med (Maywood); 2013 May; 238(5):450-60. PubMed ID: 23856898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse roles of mtDNA in schizophrenia: Implications in its pathophysiology and as biomarker for cognitive impairment.
    Suárez-Méndez S; García-de la Cruz DD; Tovilla-Zárate CA; Genis-Mendoza AD; Ramón-Torres RA; González-Castro TB; Juárez-Rojop IE
    Prog Biophys Mol Biol; 2020 Sep; 155():36-41. PubMed ID: 32437701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative neuroprotective agents in neuropsychiatric disorders.
    Dodd S; Maes M; Anderson G; Dean OM; Moylan S; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Apr; 42():135-45. PubMed ID: 23178231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.